Quince Therapeutics Inc. (QNCX) PT Lowered to $4 at D. Boral Capital
Tweet Send to a Friend
D. Boral Capital analyst Jason Kolbert lowered the price target on Quince Therapeutics Inc. (NASDAQ: QNCX) to $4.00 (from $12.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
